These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 15619463)
21. [Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations]. Azulay JP; Durif F; Rogez R; Tranchant C; Bourdeix I; Rerat K Rev Neurol (Paris); 2008 Apr; 164(4):354-62. PubMed ID: 18439927 [TBL] [Abstract][Full Text] [Related]
22. Fatigue assessment questionnaire: standardization of a cancer-specific instrument based on the general population. Beutel ME; Hinz A; Albani C; Brahler E Oncology; 2006; 70(5):351-7. PubMed ID: 17179729 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive assessment of peri-operative fatigue: development of the Identity-Consequence Fatigue Scale. Paddison JS; Booth RJ; Hill AG; Cameron LD J Psychosom Res; 2006 Jun; 60(6):615-22. PubMed ID: 16731236 [TBL] [Abstract][Full Text] [Related]
24. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Hutchison LC; Jones SK; West DS; Wei JY Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261 [TBL] [Abstract][Full Text] [Related]
25. The relation of testosterone levels with fatigue and apathy in Parkinson's disease. Kenangil G; Orken DN; Ur E; Forta H; Celik M Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155 [TBL] [Abstract][Full Text] [Related]
26. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Evers AW; Duller P; van de Kerkhof PC; van der Valk PG; de Jong EM; Gerritsen MJ; Otero E; Verhoeven EW; Verhaak CM; Kraaimaat FW Br J Dermatol; 2008 Jan; 158(1):101-8. PubMed ID: 17999699 [TBL] [Abstract][Full Text] [Related]
27. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients. Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342 [TBL] [Abstract][Full Text] [Related]
28. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS). Benito-León J; Martínez-Martín P; Frades B; Martínez-Ginés ML; de Andrés C; Meca-Lallana JE; Antigüedad AR; Huete-Antón B; Rodríguez-García E; Ruiz-Martínez J Mult Scler; 2007 Jun; 13(5):645-51. PubMed ID: 17548445 [TBL] [Abstract][Full Text] [Related]
29. [Psychometric properties of a German version of the Apathy Evaluation Scale]. Lueken U; Seidl U; Schwarz M; Völker L; Naumann D; Mattes K; Schröder J; Schweiger E Fortschr Neurol Psychiatr; 2006 Dec; 74(12):714-22. PubMed ID: 17167730 [TBL] [Abstract][Full Text] [Related]
30. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
31. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946 [TBL] [Abstract][Full Text] [Related]
33. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH; Klasser M; Reichmann H Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [TBL] [Abstract][Full Text] [Related]
34. Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. Havlikova E; Rosenberger J; Nagyova I; Middel B; Dubayova T; Gdovinova Z; W Groothoff J; P van Dijk J Parkinsonism Relat Disord; 2008; 14(3):187-92. PubMed ID: 17890136 [TBL] [Abstract][Full Text] [Related]
35. [Reconsidering fatigue at the onset of multiple sclerosis]. Debouverie M; Pittion-Vouyovitch S; Guillemin F Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S135-44. PubMed ID: 19361678 [TBL] [Abstract][Full Text] [Related]
36. Emotional care experienced by hospitalised patients: development and testing of a measurement instrument. Williams AM; Kristjanson LJ J Clin Nurs; 2009 Apr; 18(7):1069-77. PubMed ID: 19077011 [TBL] [Abstract][Full Text] [Related]
37. Rasch psychometric validation of the Impact on Participation and Autonomy questionnaire in people with Parkinson's disease. Franchignoni F; Ferriero G; Giordano A; Guglielmi V; Picco D Eura Medicophys; 2007 Dec; 43(4):451-61. PubMed ID: 18084167 [TBL] [Abstract][Full Text] [Related]
38. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. Butt Z; Wagner LI; Beaumont JL; Paice JA; Peterman AH; Shevrin D; Von Roenn JH; Carro G; Straus JL; Muir JC; Cella D J Pain Symptom Manage; 2008 Jan; 35(1):20-30. PubMed ID: 17959345 [TBL] [Abstract][Full Text] [Related]
39. Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease? Elbers R; van Wegen EE; Rochester L; Hetherington V; Nieuwboer A; Willems AM; Jones D; Kwakkel G Mov Disord; 2009 Jul; 24(10):1512-8. PubMed ID: 19514069 [TBL] [Abstract][Full Text] [Related]
40. Development and psychometric testing of the relocation self-efficacy scale. Rossen EK; Gruber KJ Nurs Res; 2007; 56(4):244-51. PubMed ID: 17625463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]